 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/14/2021 |
$1.67 |
$1.75 |
$1.66 |
$1.67 |
127.20K | | 04/15/2021 |
$1.66 |
$1.75 |
$1.65 |
$1.67 |
85.50K | | 04/16/2021 |
$1.73 |
$1.73 |
$1.60 |
$1.64 |
152.90K | | 04/19/2021 |
$1.60 |
$1.62 |
$1.55 |
$1.57 |
117.40K | | 04/20/2021 |
$1.52 |
$1.59 |
$1.51 |
$1.55 |
89.60K |
|
|
| Navidea Biopharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Co. is developing multiple precision-targeted products based on its Manocept™ platform to improve patient care by identifying the sites and pathways of undetected disease and enable diagnostic, clinical decision-making and targeted treatment. Co.'s business is focused on two primary types of drug products: diagnostic substances, including Tc99m tilmanocept and other diagnostic applications of its Manocept platform and NAV4694; and therapeutic development programs, including therapeutic applications of its Manocept platform. | |
|
Navidea Biopharmaceuticals (NAVB) has the following price history information. Looking back at NAVB historical stock prices for the last five trading days, on April 14, 2021, NAVB opened at $1.67, traded as high as $1.75 and as low as $1.66, and closed at $1.67. Trading volume was a total of 127.20K shares. On April 15, 2021, NAVB opened at $1.66, traded as high as $1.75 and as low as $1.65, and closed at $1.67. Trading volume was a total of 85.50K shares. On April 16, 2021, NAVB opened at $1.73, traded as high as $1.73 and as low as $1.60, and closed at $1.64. Trading volume was a total of 152.90K shares. On April 19, 2021, NAVB opened at $1.60, traded as high as $1.62 and as low as $1.55, and closed at $1.57. Trading volume was a total of 117.40K shares. On April 20, 2021, NAVB opened at $1.52, traded as high as $1.59 and as low as $1.51, and closed at $1.55. Trading volume was a total of 89.60K shares.
NAVB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Navidea Biopharmaceuticals shares, starting with a $10,000 purchase of NAVB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/21/2011 |
|
| End date: |
04/20/2021 |
|
| Start price/share: |
$90.60 |
|
| End price/share: |
$1.55 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.29% |
|
| Average Annual Total Return: |
-33.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$171.05 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 04/14/2021 | $1.67 | | 04/15/2021 | $1.67 | | 04/16/2021 | $1.64 | | 04/19/2021 | $1.57 | | 04/20/2021 | $1.55 |
|
|
